Status:
COMPLETED
Double-blind Clinical Trials of Probiotic Products in Oral Health.
Lead Sponsor:
Glac Biotech Co., Ltd
Conditions:
Probiotics
Oral Health
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
In order to evaluate the effects of supplementary probiotics and their metabolites on oral environment and oral microbiota, Taiwan FDA No. 88037803 will be used to evaluate the effects of oral probiot...
Eligibility Criteria
Inclusion
- Adults between 20 to 40 years old.
- More than 10\^5 Streptococcus mutans (CFU/mL) of saliva.
Exclusion
- Smoking.
- Subject has major illness.
Key Trial Info
Start Date :
October 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 6 2019
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04289337
Start Date
October 21 2019
End Date
December 6 2019
Last Update
February 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glac Biotech Co., Ltd
Tainan, Taiwan, 802